Spots Global Cancer Trial Database for NEO: Neoadjuvant Chemotherapy, Excision and Observation for Early Rectal Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: NEO: Neoadjuvant Chemotherapy, Excision and Observation for Early Rectal Cancer
Official Title: NEO: Neoadjuvant Chemotherapy, Excision and Observation for Early Rectal Cancer
Study ID: NCT03259035
Conditions
Study Description
Brief Summary: The purpose of this study is to find out the effects of chemotherapy followed by less invasive surgery on patients and their early rectal cancer. The approach of this trial will be considered a success if at least 65% of participants are able to keep the rectum.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
UC Irvine Medical Center, Orange, California, United States
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Virginia Mason Medical Center, Seattle, Washington, United States
BCCA - Vancouver Cancer Centre, Vancouver, British Columbia, Canada
St. Paul's Hospital, Vancouver, British Columbia, Canada
CancerCare Manitoba, Winnipeg, Manitoba, Canada
QEII Health Sciences Centre, Halifax, Nova Scotia, Canada
Kingston Health Sciences Centre, Kingston, Ontario, Canada
Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
Health Sciences North, Sudbury, Ontario, Canada
The Research Institute of the McGill University, Montreal, Quebec, Canada
Contact Details
Name: Hagen Kennecke
Affiliation: Virginia Mason Medical Centre, WA USA
Role: STUDY_CHAIR
Name: Carl Brown
Affiliation: St. Paul's Hospital, Vancouver BC
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
